NCT00040040Unknown1 期
Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion
适应症
相关药物
试验速览
- 阶段
- 1 期
- 入组人数
- 20
- 试验地点
- 4
- 主要终点
- Psychological effects
研究概览
简要总结
The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.
详细描述
This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Diagnostic
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Please contact site director for more details.
排除标准
- •Please contact site director for more details.
结局指标
主要结局
Psychological effects
BP, HR
次要结局
未报告次要终点
研究者
研究点 (4)
Loading locations...
相似试验
Unknown
1 期
Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1Amphetamine-Related DisordersNCT00265278National Institute on Drug Abuse (NIDA)16
已完成
1 期
Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)Methamphetamine DependenceMethamphetamine AbuseNCT00603434University of Cincinnati16
Unknown
1 期
A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1Amphetamine-Related DisordersNCT00267657National Institute on Drug Abuse (NIDA)30
Unknown
1 期
Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Amphetamine-Related DisordersNCT00033072National Institute on Drug Abuse (NIDA)16
Unknown
1 期
Assessment of Interactions Between Methamphetamine and Aripiprazole - 1Amphetamine-Related DisordersNCT00089440National Institute on Drug Abuse (NIDA)17